Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).

NCT02883478 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Keratoconus
Corneal Ectasia

Interventions

DEVICE: UV-X 1000 (3 mW/cm²)
PROCEDURE: UV-X 2000 (9 mW/cm²)
DRUG: riboflavin with hydroxypropyl methylcellulose

Sponsor

Oslo University Hospital